Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 12-09 16:00:00 EST

70.22

-1.00

-1.40%

High71.48	Low70.17	Vol780.46M
Open71.22	D1 Closing71.22	Amplitude1.83%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O16.10B	T/O Rate--	Tradable Shares0.00
P/B7.136554	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":70.221825,"timestamp":1765313999999,"preClose":71.217545,"halted":0,"volume":780463052,"delay":0,"changeRate":-0.013981,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.99572,"latestTime":"12-09 16:00:00 EST","open":71.21747,"high":71.47804,"low":70.17338,"amount":16102751062.392912,"amplitude":0.018319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765377000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.136554,"peRate":-126.259239,"turnoverRate":0.024259,"increases":218,"decrements":298,"flats":7,"marketCap":1824828242796.25,"floatMarketCap":1632694367042.875},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"2590658914","title":"Vertex Pharmaceuticals Incorporated : Wells Fargo Raises Target Price to $515 From $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2590658914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590658914?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:30","pubTimestamp":1765366227,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nAZN4RCSON:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1674673428.USD","IE00B2B36J28.USD","BK4533","BK4532","LU1778281490.HKD","IE00BZ9MQY76.HKD","BK4567","LU0234570918.USD","BK4585","LU1674673691.USD","LU1585245621.USD","BK4139","IE00BJT1NW94.SGD","LU0432979614.USD","LU0256863811.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","LU1430594728.SGD","LU2236285917.USD","LU2362541273.HKD","LU2456880835.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU0417517546.SGD","IE0002270589.USD","LU1093756168.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","SGXZ57979304.SGD","LU0889565916.HKD","LU1093756325.SGD","VRTX","LU0079474960.USD","LU2462157665.USD","LU0109394709.USD","IE00B894F039.SGD","IE00B19Z3B42.SGD","LU0061475181.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2237438978.USD","BK4588","LU1035775433.USD","LU2362541513.USD","SG9999001176.SGD","SG9999001176.USD"],"gpt_icon":0},{"id":"2590891135","title":"Biogen Inc. : Wells Fargo Raises Target Price to $190 From $155","url":"https://stock-news.laohu8.com/highlight/detail?id=2590891135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590891135?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:30","pubTimestamp":1765366226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nAZN4RCSOQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4533","BIIB","BK4585","IE00B894F039.SGD","IE00B19Z9P08.USD","BK4588","IE00B19Z9Z06.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2590147589","title":"Amgen Inc. : Wells Fargo Raises Target Price to $325 From $300","url":"https://stock-news.laohu8.com/highlight/detail?id=2590147589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590147589?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:30","pubTimestamp":1765366226,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nAZN4RCSOR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001440.SGD","LU2468319806.SGD","LU0122379950.USD","LU1983299246.USD","BK4534","LU0289739699.SGD","LU0320765992.SGD","AMGN","IE0002141913.USD","LU1061106388.HKD","LU1571399168.USD","BK4139","BK4599","LU0868494617.USD","LU0889565916.HKD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","LU0109394709.USD","BK4585","BK4588","LU2112291526.USD","IE00BJT1NW94.SGD","BK4566","BK4533","LU2089984988.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","BK4581","IE00B2B36J28.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2590586090","title":"Nurix Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $31 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2590586090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590586090?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:10","pubTimestamp":1765365029,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nAZN4RCRIP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2590586420","title":"BRIEF-Ideaya Biosciences Announces Ind Submission For Ide574","url":"https://stock-news.laohu8.com/highlight/detail?id=2590586420","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590586420?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:02","pubTimestamp":1765364546,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences Announces Ind Submission For Ide574Dec 10 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCES ANNOUNCES IND SUBMISSION FOR IDE574, A POTENTIAL FIRST-IN-CLASS KAT6/7 D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2590586483","title":"IDEAYA Biosciences- Phase 1 Dose Escalation Trial of Monotherapy Ide574 Expected to Begin in 1Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590586483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590586483?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2590558615","title":"IDEAYA Biosciences Announces Ind Submission for Ide574, a Potential First-in-Class Kat6/7 Dual Inhibitor for Breast and Lung Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2590558615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590558615?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590258610","title":"IDEAYA Biosciences Inc - Preclinical Data for Ide574 to Be Presented in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590258610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590258610?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590583775","title":"Structure Therapeutics Prices $650 Million Upsized Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590583775","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590583775?lang=en_us&edition=fundamental","pubTime":"2025-12-10 18:05","pubTimestamp":1765361145,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) said Wednesday it has priced its upsized public offering of about 8.5 million American depositary shares at $65 per ADS.The company also priced pre-funded warrants to pur","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","GPCR","BK4539","LENZ","BK4599","BK4139"],"gpt_icon":0},{"id":"2590497300","title":"Dyne Therapeutics Prices $350 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590497300","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590497300?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:13","pubTimestamp":1765358037,"startTime":"0","endTime":"0","summary":"Dyne Therapeutics  said late Tuesday it priced an upsized underwritten public offering of 19 million shares at $18.44 per share for gross proceeds of about $350 million.The offering is expected to close on Thursday.In addition, Dyne said it has granted the underwriters a 30-day option to purchase up to an additional 2.8 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4505","BK4585","BK4139","DYN"],"gpt_icon":0},{"id":"2590627300","title":"Vera Therapeutics Prices $261 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590627300","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590627300?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:09","pubTimestamp":1765357786,"startTime":"0","endTime":"0","summary":"Vera Therapeutics  said Tuesday that it has priced an underwritten public offering of about 6.1 million shares at $42.50 each.The gross proceeds are expected to be around $261 million, the company said.The offering is expected to close on Thursday.The company has also granted underwriters a 30-day option to purchase up to 920,716 additional shares.Shares of the company were down over 3% in recent premarket activity Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4588","BK4139","VERA","BK4585"],"gpt_icon":0},{"id":"2590307522","title":"Vertex 1H Net Y1.44B Vs Net Y1.45B","url":"https://stock-news.laohu8.com/highlight/detail?id=2590307522","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590307522?lang=en_us&edition=fundamental","pubTime":"2025-12-10 16:43","pubTimestamp":1765356180,"startTime":"0","endTime":"0","summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU2456880835.USD","IE00B19Z9P08.USD","LU1815336091.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU2237438978.USD","IE0002141913.USD","LU0109394709.USD","BK4567","LU0823416689.USD","BK4023","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0061475181.USD","LU1430594728.SGD","LU1674673691.USD","LU1093756168.USD","IE00B19Z3581.USD","LU2324357040.USD","LU1559883803.SGD","VERX","LU0079474960.USD","BK4532","LU0289739699.SGD","IE00B2B36J28.USD","VRTX","IE00BJJMRZ35.SGD","LU1674673428.USD","LU0757428866.USD","SG9999001176.USD","IE00BZ9MQY76.HKD","BK4533","LU1778281490.HKD","LU2462157665.USD","LU2362540622.SGD","IE0002270589.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","IE0009355771.USD","LU2362541513.USD","BK4139","LU0566484027.USD","LU1585245621.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","IE00B894F039.SGD"],"gpt_icon":0},{"id":"2590054413","title":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590054413","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590054413?lang=en_us&edition=fundamental","pubTime":"2025-12-10 14:43","pubTimestamp":1765349009,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer Dec 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including JP Morgan, Pepsi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBI","IE00BDGV0183.EUR","DE","SATS","LU1989763690.USD","LU1037948541.HKD","AMGN","AMRZ","AVBP","CNM","LU2089984988.USD","BMY","T","LU0820561909.HKD","ASMB","CARR","BDX","LU1934455194.USD","AU","CAT","LU0006061336.USD","CMC","CAPR","LU0198837287.USD","CBRL","COF","CF","ANDE","PLAY","AZO","ELAN","LU0976567544.SGD","BK4195","BWB","CPB","CVS","BK4102","BTI","ABBV","AVAV","BRZE","BK4585","APD","APGE","ASO","CMCSA","BIIB","BLLN","ANF","CHD"],"gpt_icon":1},{"id":"2590585305","title":"How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2590585305","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590585305?lang=en_us&edition=fundamental","pubTime":"2025-12-10 13:23","pubTimestamp":1765344193,"startTime":"0","endTime":"0","summary":"Tyra Biosciences recently strengthened its leadership team by appointing Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, both bringing extensive oncology and regulatory experience from major biopharma companies.\nTheir track records in securing approvals for complex medicines and launching rare oncology products could be particularly important as Tyra advances oral dabogratinib through global Phase 2 studies.\nWith these leadership changes in place,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tyra/tyra-biosciences/news/how-investors-are-reacting-to-tyra-biosciences-tyra-bolsteri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tyra/tyra-biosciences/news/how-investors-are-reacting-to-tyra-biosciences-tyra-bolsteri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4211","BK4139","TYRA"],"gpt_icon":0},{"id":"2590088823","title":"BRIEF-Denali Therapeutics Says Co Prices Public Offering Of 9.14 Mln Shares At $17.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2590088823","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590088823?lang=en_us&edition=fundamental","pubTime":"2025-12-10 13:18","pubTimestamp":1765343921,"startTime":"0","endTime":"0","summary":"BRIEF-Denali Therapeutics Says Co Prices Public Offering Of 9.14 Mln Shares At $17.50 EachDec 10 (Reuters) - Denali Therapeutics Inc DNLI.O:DENALI THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA5J6P14:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4548","DNLI"],"gpt_icon":0},{"id":"2590770370","title":"Denali Therapeutics Inc - Prices Public Offering of 9,142,857 Shares at $17.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2590770370","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590770370?lang=en_us&edition=fundamental","pubTime":"2025-12-10 13:14","pubTimestamp":1765343666,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA5J6P14:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4535","DNLI","BK4139"],"gpt_icon":0},{"id":"2590370811","title":"BRIEF-Kymera Therapeutics Announces Pricing Of Upsized $602 Million Public Offering At $86 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590370811","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590370811?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:31","pubTimestamp":1765341073,"startTime":"0","endTime":"0","summary":"BRIEF-Kymera Therapeutics Announces Pricing Of Upsized $602 Million Public Offering At $86 Per ShareDec 9 (Reuters) - Kymera Therapeutics Inc KYMR.O:KYMERA THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $6","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA79TXS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"gpt_icon":0},{"id":"2590637081","title":"Kymera Therapeutics Inc - Selling 7,000,000 Shares at $86 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590637081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590637081?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:30","pubTimestamp":1765341000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA79TXS7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"gpt_icon":0},{"id":"2590377087","title":"Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377087?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:30","pubTimestamp":1765341000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA79TXS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"gpt_icon":0},{"id":"2590110370","title":"Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2590110370","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590110370?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:15","pubTimestamp":1765340100,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Dec.  09, 2025  (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for m","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/10/3202894/0/en/Structure-Therapeutics-Announces-Pricing-of-Upsized-650-Million-Public-Offering-of-ADSs-and-Pre-Funded-Warrants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU0106831901.USD","LU1720051108.HKD","LU2271345857.HKD","LU0158827781.USD","LU0557290698.USD","BK4139","LU1720051017.SGD","BK4585","BK4599","LU1363072403.SGD","LU0882574139.USD","LU2347655156.SGD","LU1791710582.SGD","LU2023251221.USD","LU2111349929.HKD","IE00BKVL7J92.USD","GPCR","LU0098860793.USD","LU2133065610.SGD","LU2357305700.SGD","LU0267386448.USD","LU1732800096.USD","LU1791710400.SGD","LU2028103732.USD","BK4007","LU1989772840.SGD","LU1244550494.USD","BK4588","LU2089283258.USD","LU0106261372.USD","LU1668664300.SGD","LU1732799900.SGD","LU1244550577.SGD","BK4581","BK4504","LU1548497426.USD","LENZ","BK4534","LU0320765646.SGD","LU0528227936.USD","LU0795875086.SGD","LU0158827948.USD","LU0795875169.SGD","LU1162221912.USD","LU0225283273.USD","LU0971096721.USD","LU0314104364.USD","LU0006306889.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.018},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.1313},{"period":"1year","weight":0.1296},{"period":"ytd","weight":0.1654}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}